50-228-0785
c-Myc Polyclonal Antibody, Cyanine3, Bioss
Manufacturer: Bioss
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 50-228-0785-Each-of-1 | In Stock | ₹ 18,891.65 |
50-228-0785 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 18,891.65
GST (18%): ₹ 3,400.497
Total Price: ₹ 22,292.147
Antigen
c-Myc
Classification
Polyclonal
Conjugate
Cyanine3
Gene Alias
46-0603; AU016757; avian myelocytomatosis viral oncogene homolog; bHLHe39; c Myc; class E basic helix-loop-helix protein 39; cmyc; c-Myc; c-myc epitope tag; c-myc proto-oncogene; MRTL; MYC; Myc protein; Myc proto-oncogene protein; Myc Tag; Myc2; MYCC; myc-related translation/localization regulatory factor; myelocytomatosis oncogene; Niard; Nird; Proto-oncogene c-Myc; R95025; R950-25; transcription factor p64; v-myc avian myelocytomatosis viral oncogene homolog; v-myc myelocytomatosis viral oncogene homolog
Immunogen
KLH conjugated synthetic peptide corresponding to amino acids 408-437 of human Myc
Quantity
100 μL
Primary or Secondary
Primary
Product Type
Antibody
Isotype
IgG
Applications
Immunocytochemistry, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin)
Concentration
1 mg/mL
Formulation
TBS with 1% BSA, 50% glycerol and 0.03% ProClin 300
Host Species
Rabbit
Purification Method
Protein A
Regulatory Status
RUO
Content And Storage
-20°C or -80°C if preferred
Form
Liquid
Target Molecule
Tag
Related Products
Description
- c-Myc Polyclonal antibody specifically detects c-Myc in Tag samples
- It is validated for Immunocytochemistry, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin)
Compare Similar Items
Show Difference
Antigen: c-Myc
Classification: Polyclonal
Conjugate: Cyanine3
Gene Alias: 46-0603; AU016757; avian myelocytomatosis viral oncogene homolog; bHLHe39; c Myc; class E basic helix-loop-helix protein 39; cmyc; c-Myc; c-myc epitope tag; c-myc proto-oncogene; MRTL; MYC; Myc protein; Myc proto-oncogene protein; Myc Tag; Myc2; MYCC; myc-related translation/localization regulatory factor; myelocytomatosis oncogene; Niard; Nird; Proto-oncogene c-Myc; R95025; R950-25; transcription factor p64; v-myc avian myelocytomatosis viral oncogene homolog; v-myc myelocytomatosis viral oncogene homolog
Immunogen: KLH conjugated synthetic peptide corresponding to amino acids 408-437 of human Myc
Quantity: 100 μL
Primary or Secondary: Primary
Product Type: Antibody
Isotype: IgG
Applications: Immunocytochemistry, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin)
Concentration: 1 mg/mL
Formulation: TBS with 1% BSA, 50% glycerol and 0.03% ProClin 300
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Content And Storage: -20°C or -80°C if preferred
Form: Liquid
Target Molecule: Tag
Antigen:
c-Myc
Classification:
Polyclonal
Conjugate:
Cyanine3
Gene Alias:
46-0603; AU016757; avian myelocytomatosis viral oncogene homolog; bHLHe39; c Myc; class E basic helix-loop-helix protein 39; cmyc; c-Myc; c-myc epitope tag; c-myc proto-oncogene; MRTL; MYC; Myc protein; Myc proto-oncogene protein; Myc Tag; Myc2; MYCC; myc-related translation/localization regulatory factor; myelocytomatosis oncogene; Niard; Nird; Proto-oncogene c-Myc; R95025; R950-25; transcription factor p64; v-myc avian myelocytomatosis viral oncogene homolog; v-myc myelocytomatosis viral oncogene homolog
Immunogen:
KLH conjugated synthetic peptide corresponding to amino acids 408-437 of human Myc
Quantity:
100 μL
Primary or Secondary:
Primary
Product Type:
Antibody
Isotype:
IgG
Applications:
Immunocytochemistry, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin)
Concentration:
1 mg/mL
Formulation:
TBS with 1% BSA, 50% glycerol and 0.03% ProClin 300
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Content And Storage:
-20°C or -80°C if preferred
Form:
Liquid
Target Molecule:
Tag
Antigen: Thrombin Activation peptide fragment 1
Classification: Polyclonal
Conjugate: Cyanine5
Gene Alias: Activation peptide fragment 1; Activation peptide fragment 2; Coagulation factor II; coagulation factor II (thrombin); coagulation factor II, thrombin; F2; prepro-coagulation factor II; prothrombin; prothrombin B-chain; PT; RPRGL2; serine protease; THPH1; Thrombin heavy chain; Thrombin light chain
Immunogen: KLH conjugated synthetic peptide derived from human Thrombin Activation peptide fragment 1 (51-150).
Quantity: 100 μL
Primary or Secondary: Primary
Product Type: Antibody
Isotype: IgG
Applications: Immunocytochemistry, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin)
Concentration: 1 mg/mL
Formulation: TBS with 1% BSA, 50% glycerol and 0.03% ProClin 300
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Content And Storage: -20°C or -80°C if preferred
Form: Liquid
Target Molecule: __
Antigen:
Thrombin Activation peptide fragment 1
Classification:
Polyclonal
Conjugate:
Cyanine5
Gene Alias:
Activation peptide fragment 1; Activation peptide fragment 2; Coagulation factor II; coagulation factor II (thrombin); coagulation factor II, thrombin; F2; prepro-coagulation factor II; prothrombin; prothrombin B-chain; PT; RPRGL2; serine protease; THPH1; Thrombin heavy chain; Thrombin light chain
Immunogen:
KLH conjugated synthetic peptide derived from human Thrombin Activation peptide fragment 1 (51-150).
Quantity:
100 μL
Primary or Secondary:
Primary
Product Type:
Antibody
Isotype:
IgG
Applications:
Immunocytochemistry, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin)
Concentration:
1 mg/mL
Formulation:
TBS with 1% BSA, 50% glycerol and 0.03% ProClin 300
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Content And Storage:
-20°C or -80°C if preferred
Form:
Liquid
Target Molecule:
__
Antigen: CK4
Classification: Polyclonal
Conjugate: HRP
Gene Alias: 57kd keratin; 57kDa keratin; AW108092; cb59; CK4; CK-4; CYK4; cytokeratin; cytokeratin 4; cytokeratin-4; Cytoskeletal 57 kDa keratin; etID20321.6; FLJ31692; intermediate filament protein; K4; Kb4; keratin 4; keratin 4, type II; keratin 8; keratin complex 2, basic, gene 4; keratin, type II cytoskeletal 4; Keratin-4; Krt-2.4; Krt2-4; Krt4; krt4 {ECO:0000250; krt4 protein; krt8; type II basic cytokeratin; type II keratin Kb4; type-II keratin Kb4; UniProtKB:P19013}; WSN1; wu:fa91a11; wu:fd19e09; wu:fl23c09; zf-K8
Immunogen: KLH conjugated synthetic peptide derived from human CK4
Quantity: 100 μL
Primary or Secondary: Primary
Product Type: Antibody
Isotype: IgG
Applications: Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin), Western Blot
Concentration: 1 mg/mL
Formulation: TBS with 1% BSA, 50% glycerol and 0.03% ProClin 300
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Content And Storage: -20°C or -80°C if preferred
Form: Liquid
Target Molecule: __
Antigen:
CK4
Classification:
Polyclonal
Conjugate:
HRP
Gene Alias:
57kd keratin; 57kDa keratin; AW108092; cb59; CK4; CK-4; CYK4; cytokeratin; cytokeratin 4; cytokeratin-4; Cytoskeletal 57 kDa keratin; etID20321.6; FLJ31692; intermediate filament protein; K4; Kb4; keratin 4; keratin 4, type II; keratin 8; keratin complex 2, basic, gene 4; keratin, type II cytoskeletal 4; Keratin-4; Krt-2.4; Krt2-4; Krt4; krt4 {ECO:0000250; krt4 protein; krt8; type II basic cytokeratin; type II keratin Kb4; type-II keratin Kb4; UniProtKB:P19013}; WSN1; wu:fa91a11; wu:fd19e09; wu:fl23c09; zf-K8
Immunogen:
KLH conjugated synthetic peptide derived from human CK4
Quantity:
100 μL
Primary or Secondary:
Primary
Product Type:
Antibody
Isotype:
IgG
Applications:
Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin), Western Blot
Concentration:
1 mg/mL
Formulation:
TBS with 1% BSA, 50% glycerol and 0.03% ProClin 300
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Content And Storage:
-20°C or -80°C if preferred
Form:
Liquid
Target Molecule:
__
Antigen: CDKN2A/p16-INK4a
Classification: Polyclonal
Conjugate: Cyanine3
Gene Alias: Alternative reading frame; Arf; ARF-INK4a; CDK4 inhibitor p16 INK4; CDK4 inhibitor p16-INK4; CDK4I; CDKN2; Cdkn2a; cdkn2a {ECO:0000312; cell cycle inhibitor; cell cycle negative regulator beta; cell cycle regulator; CMM2; Cyclin dependent kinase 4 inhibitor A; cyclin dependent kinase inhibitor 2A; Cyclin dependent kinase inhibitor 2A (p16, inhibits CDK4); cyclin-dependent kinase 4 inhibitor A; Cyclin-dependent kinase inhibitor 2A; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4); cyclin-dependent kinase inhibitor 2a p16Ink4a; cyclin-dependent kinase inhibitor 2a p19Arf; cyclin-dependent kinase inhibitor 2A, isoform 1; cyclin-dependent kinase inhibitor 2A, isoform 2; cyclin-dependent kinase inhibitor 2A, isoform 3; cyclin-dependent kinase inhibitor 2A, isoforms 1/2; cyclin-dependent kinase inhibitor protein; EMBL:AAL76336.1, ECO:0000312; EMBL:AAL76338.1, ECO:0000312; HGNC:1787; inhibits CDK4; INK4; INK4A; Ink4a/Arf; INK4a-ARF; isoforms 1/2/3; Melanoma p16 inhibits CDK4; mitochondrial smARF; MLM; MTS1; MTS-1; Multiple tumor suppressor 1; P14; P14 P16; P14ARF; p16; p16(INK4a); p16Cdkn2a; P16INK4; p16-INK4; p16INK4a; p16-INK4a; P19; P19 TP16; p19<ARF>; P19ARF; Pctr1; RGD:2323}; TP16; Tumor suppressor ARF
Immunogen: KLH conjugated synthetic peptide derived from human CDKN2A/p16-INK4a (amino acids 61-156).
Quantity: 100 μL
Primary or Secondary: Primary
Product Type: Antibody
Isotype: IgG
Applications: Immunocytochemistry, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin)
Concentration: 1 mg/mL
Formulation: TBS with 1% BSA, 50% glycerol and 0.03% ProClin 300
Host Species: Rabbit
Purification Method: Protein A
Regulatory Status: RUO
Content And Storage: -20°C or -80°C if preferred
Form: Liquid
Target Molecule: __
Antigen:
CDKN2A/p16-INK4a
Classification:
Polyclonal
Conjugate:
Cyanine3
Gene Alias:
Alternative reading frame; Arf; ARF-INK4a; CDK4 inhibitor p16 INK4; CDK4 inhibitor p16-INK4; CDK4I; CDKN2; Cdkn2a; cdkn2a {ECO:0000312; cell cycle inhibitor; cell cycle negative regulator beta; cell cycle regulator; CMM2; Cyclin dependent kinase 4 inhibitor A; cyclin dependent kinase inhibitor 2A; Cyclin dependent kinase inhibitor 2A (p16, inhibits CDK4); cyclin-dependent kinase 4 inhibitor A; Cyclin-dependent kinase inhibitor 2A; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4); cyclin-dependent kinase inhibitor 2a p16Ink4a; cyclin-dependent kinase inhibitor 2a p19Arf; cyclin-dependent kinase inhibitor 2A, isoform 1; cyclin-dependent kinase inhibitor 2A, isoform 2; cyclin-dependent kinase inhibitor 2A, isoform 3; cyclin-dependent kinase inhibitor 2A, isoforms 1/2; cyclin-dependent kinase inhibitor protein; EMBL:AAL76336.1, ECO:0000312; EMBL:AAL76338.1, ECO:0000312; HGNC:1787; inhibits CDK4; INK4; INK4A; Ink4a/Arf; INK4a-ARF; isoforms 1/2/3; Melanoma p16 inhibits CDK4; mitochondrial smARF; MLM; MTS1; MTS-1; Multiple tumor suppressor 1; P14; P14 P16; P14ARF; p16; p16(INK4a); p16Cdkn2a; P16INK4; p16-INK4; p16INK4a; p16-INK4a; P19; P19 TP16; p19<ARF>; P19ARF; Pctr1; RGD:2323}; TP16; Tumor suppressor ARF
Immunogen:
KLH conjugated synthetic peptide derived from human CDKN2A/p16-INK4a (amino acids 61-156).
Quantity:
100 μL
Primary or Secondary:
Primary
Product Type:
Antibody
Isotype:
IgG
Applications:
Immunocytochemistry, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin)
Concentration:
1 mg/mL
Formulation:
TBS with 1% BSA, 50% glycerol and 0.03% ProClin 300
Host Species:
Rabbit
Purification Method:
Protein A
Regulatory Status:
RUO
Content And Storage:
-20°C or -80°C if preferred
Form:
Liquid
Target Molecule:
__